Valuation: Formycon AG

Market Cap 352M 396M 326M 297M 560M 37.59B 569M 3.92B 1.54B 19.61B 1.49B 1.45B 62.53B P/E 2026 *
664x
P/E 2027 * 15x
Enterprise Value 466M 525M 432M 393M 742M 49.78B 754M 5.19B 2.04B 25.98B 1.97B 1.93B 82.81B EV / Sales 2026 *
6.42x
EV / Sales 2027 * 4.14x
Free-Float
69.59%
Yield 2026 *
-
Yield 2027 * -
1 day-0.45%
1 week+1.34%
Current month+1.96%
1 month+2.49%
3 months+9.31%
6 months+3.90%
Current year-22.97%
1 week 19.26
Extreme 19.26
22.1
1 month 18.3
Extreme 18.3
22.1
Current year 15.8
Extreme 15.8
26.95
1 year 15.8
Extreme 15.8
26.95
3 years 15.8
Extreme 15.8
67.8
5 years 15.8
Extreme 15.8
94.1
10 years 14.65
Extreme 14.65
94.1
Manager TitleAgeSince
Chief Executive Officer - 30/06/2022
Director of Finance/CFO 57 31/03/2023
Chief Tech/Sci/R&D Officer - 30/06/2022
Director TitleAgeSince
Director/Board Member 49 09/12/2020
Chairman 54 11/06/2024
Director/Board Member 54 11/06/2024
Date Insider Type Main position Quantity % Market Cap. Importance
21/02/25 Buy

Chief Technology Officer

160 0.0009%
29/04/24 Buy

Executive/Senior Manager

1,200 0.0068%
24/04/24 Buy

Chief Executive Officer

2,500 0.0142%
Change 5-day change 1-year change 3-year change Capi.($)
-0.45%+1.34%-16.97%-61.71% 396M
+1.52%-7.16%+51.66%+67.41% 65B
+0.88%+6.34%+10.38%+78.48% 51.2B
+0.33%-0.52%-0.08%+61.80% 51.19B
-1.53%+2.70%+30.48%+41.25% 43.93B
-1.34%+4.12%+16.64%+120.28% 41.96B
-5.97%-6.22%+228.95%+483.48% 38.14B
+2.16%+10.36%+18.92%+59.70% 33.24B
-0.90%-10.49%+37.09%+1.80% 25.2B
+0.16%+0.68%+26.05%+26.08% 22.5B
Average -0.52%+0.58%+40.31%+87.86% 37.28B
Weighted average by Cap. -0.38%+0.04%+45.06%+105.85%

Financials

2026 *2027 *
Net sales 72.66M 81.74M 67.34M 61.27M 116M 7.76B 117M 809M 317M 4.05B 307M 300M 12.9B 112M 126M 104M 94.77M 179M 12B 182M 1.25B 491M 6.26B 474M 464M 19.96B
Net income 343K 386K 318K 289K 546K 36.62M 555K 3.82M 1.5M 19.11M 1.45M 1.42M 60.92M 23.19M 26.09M 21.49M 19.56M 36.9M 2.48B 37.5M 258M 101M 1.29B 97.91M 95.83M 4.12B
Net Debt 114M 128M 106M 96.3M 182M 12.19B 185M 1.27B 499M 6.36B 482M 472M 20.28B 113M 128M 105M 95.63M 180M 12.11B 183M 1.26B 495M 6.32B 479M 469M 20.14B
Projected Income Statement - Annual - Formycon AG
Logo Formycon AG
Formycon AG is a Germany based Company. The Company is engaged in providing biosimilar drugs and formulations. The Company focuses on treatments in ophthalmology, immunology and other chronic diseases, covering all steps of biosimilar development process, from early-stage analysis of the originator drug to the preclinical and clinical testing phases, as well as the preparation of dossiers for marketing approval.
Employees
196
Date Price Change Volume
19/10/26 €19.72 -1.00% 841
16/10/26 €19.92 +2.68% 1,496
15/10/26 €19.40 -4.20% 8,206
14/10/26 €20.25 -5.81% 2,125
13/10/26 €21.50 +10.48% 29,533
Trader
Investor
-
Global
-
Quality
ESG MSCI
B
MarketScreener Ratings - Formycon AG
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
7
Last Close Price
19.92EUR
Average target price
40.67EUR
Spread / Average Target
+104.15%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Formycon AG